menu search

Rhythm pharmaceuticals, inc. (rytm) ceo david meeker on q2 2022 results - earnings call transcript

Rhythm pharmaceuticals, Inc. (NASDAQ:RYTM ) Q2 2022 Results Earnings Conference Call August 2, 2022 8:0...

August 2, 2022, 11:23 am

Volitionrx limited inks r&d collaboration deals with xenetic biosciences and salarius pharmaceuticals in push to develop cancer treatments

VolitionRx (NYSE-A:VNRX) Limited has inked a pair of research and development collaborations that will develop targeted, adoptive cell therapies to ...

August 2, 2022, 10:07 am

Pharmadrug announces non-brokered offering of $650,000 of convertible secured debentures and issuance of shares

PharmaDrug Inc, which focuses on the research, development and commercialization of controlled substances and natural medicines such as psychedelics, ...

August 2, 2022, 9:29 am

Valeo pharma enters commercialization and supply agreement with novartis canada for two ophthalmic therapies

Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) said it has entered into a commercialization and supply agreement with Novartis ...

August 2, 2022, 8:01 am

Tonix pharmaceuticals (tnxp) stock surges 15% on patent news

Clinical-stage biotechnology firm Tonix pharmaceuticals (NASDAQ: TNXP ) – which focuses on novel ther...

August 1, 2022, 12:47 pm

Reata pharmaceuticals, inc. to report second quarter 2022 financial results and to provide an update on clinical development programs on august 8, 2022

PLANO, Texas--(BUSINESS WIRE)--Reata pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,...

August 1, 2022, 6:45 am

Sage therapeutics to present at upcoming august investor conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company ...

August 1, 2022, 6:30 am

Amphastar pharmaceuticals to release second quarter earnings and hold conference call on august 8, 2022

RANCHO CUCAMONGA, CA / ACCESSWIRE / August 1, 2022 / Amphastar pharmaceuticals, Inc. (NASDAQ:AMPH) anno...

August 1, 2022, 6:05 am

Tonix pharmaceuticals (tnxp) stock: why it fell 10.16%

The stock price of Tonix pharmaceuticals (TNXP) fell by 10.16% in the previous trading session. This is...

July 31, 2022, 12:40 pm

Takeda pharmaceutical company limited (tak) ceo christophe weber on q1 2022 results - earnings call transcript

Takeda pharmaceutical Company Limited (NYSE:TAK ) Q1 2022 Results Conference Call July 28, 2022 6:00 AM...

July 29, 2022, 7:38 pm

Concert pharmaceuticals to report second quarter 2022 results on august 4, 2022

LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #AlopeciaAreata--Concert will report its financial results for the second quarter of 2022, on Thursday, Au...

July 29, 2022, 7:00 am

Sanofi: arguably one of the most undervalued pharma stocks

I am bullish on Sanofi as I see the company undervalued as compared to both the company's financials and competitors (EU pharma peers). Sanofi is a le...

July 29, 2022, 1:31 am

Arrowhead pharmaceuticals: an rnai name to know

Shares of RNA interference concern Arrowhead pharmaceuticals are down over 50% since making an all-time...

July 28, 2022, 3:45 pm

Pfizer inc's (pfe) ceo albert bourla on q2 2022 results - earnings call transcript

Pfizer Inc. (NYSE:PFE ) Q2 2022 Earnings Conference Call July 28, 2022 10:00 AM ET Company Participants Chris Stevo – Senior Vice President and Chie...

July 28, 2022, 3:06 pm

West pharmaceutical services, inc.'s (wst) ceo eric green on q2 2022 results - earnings call transcript

West pharmaceutical Services, Inc. (NYSE:WST ) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM E...

July 28, 2022, 2:24 pm

Algernon pharmaceuticals reports further positive data from phase 2 study of ifenprodil for ipf and chronic cough

Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF), a clinical stage Canadian ...

July 28, 2022, 7:50 am

Takeda sees quarterly profit drop 39% after last year's one-time gains

Japan's Takeda pharmaceutical Co said on Thursday first-quarter profit slumped 39% percent from a year ...

July 28, 2022, 3:09 am

Genentech to present scientific progress across alzheimer's disease pharmaceutical and diagnostic portfolio at 2022 aaic annual meeting

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data from 41 a...

July 28, 2022, 1:00 am

Roche to present scientific progress across alzheimer's disease pharmaceutical and diagnostic portfolio at 2022 aaic annual meeting

Basel, 28 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that data from 41 abstracts across its portfolio of Alzheimer's disease ...

July 28, 2022, 1:00 am

Taro pharmaceutical (taro) lags q1 earnings estimates

Taro (TARO) delivered earnings and revenue surprises of -56.47% and 4.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to...

July 27, 2022, 8:54 pm


Search within

Pages Search Results: